• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.32% Nasdaq Up 0.39%

    Biogen Inc. (BIIB)

    -NasdaqGS
    299.44 Up 9.90(3.42%) 11:43AM EST - Nasdaq Real Time Price
    Prev Close:289.54
    Open:305.24
    Bid:300.18 x 200
    Ask:300.44 x 100
    1y Target Est:339.98
    Beta:0.327313
    Earnings Date:Jan 25 - Jan 30 (Est.)
    Day's Range:298.40 - 306.98
    52wk Range:223.02 - 333.65
    Volume:2,700,996
    Avg Vol (3m):1,607,060
    Market Cap:65.15B
    P/E (ttm):16.93
    EPS (ttm):17.68
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for BIIB

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 3.42%65.15B
    1 0.00%N/A
    PFEUp 2.91%193.22B
    ABTUp 0.57%57.27B

    Key Statistics

    Forward P/E (1 yr):14.41
    P/S (ttm):5.52
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :20.20
    Quarterly EPS Est (Dec-16) :4.99
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.62

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback